CTC Netherlands B.V.
Verified site
Groningen, The Netherlands
Rare diseases
Investigational molecules
Locations
A plain-language summary of the goals, design and what participants do
The study focuses on Obesity, a condition where excess body fat can lead to health problems. The investigational medicine being tested is Survodutide, which is given as a small injection under the skin. Participants will receive either this medication or a matching placebo, and the main goal is to determine whether the drug can lower the amount of fat stored around the internal organs, known as VAT, compared with the control.
During the 40‑week period, participants are randomly assigned to one of the two groups and receive regular injections. Throughout the study they will attend clinic visits where their weight, waist size, and other body measurements are checked, and they will undergo imaging scans using MRI—a type of picture‑taking that shows the inside of the body without surgery—to see changes in fat and muscle. Simple tests of muscle strength and physical performance, such as measuring the force of a knee extension or timing how quickly stairs are climbed, are also performed to assess any improvement in muscle function.
The trial runs in 8 steps – from screening to follow-up. Each step says what happens and what the team monitors.
9 criteria
34 criteria
Tell us about your condition – we search every trial in Europe and connect you with the right site.
We usually reply within a few days
All sites with verified contact details – recruitment status may not be available; ask directly
Groningen, The Netherlands
Where you can join this trial
Countries are shaded by recruitment status. Click a recruiting country to ask about joining there.
Not yet recruitingJoining a clinical trial can seem overwhelming. We guide you step by step, so you know exactly what to expect and how we support you through the process.
Survodutide is an experimental medicine that is given as a liquid that is injected just under the skin. In this study it is being tested to see if it can help people who are obese lower the amount of fat around their internal organs (visceral fat) and improve how their muscles work. Participants receive the injection regularly over 40 weeks, and researchers compare the changes in their body fat and muscle function to those who receive a placebo.
sourced from the EU Clinical Trials Register and site verification
Want to learn more about this trial or check if you can participate?
Tell us about your condition – we search every trial in Europe and connect you with the right site.